Language selection

Search

2009-02-17 - Male

318543

Adverse reaction report number 318543
Latest AER version number 0
Market authorization holder AER number SPV1200900216
Initial received date 2009-02-17
Latest received date 2009-02-17
Age N/A
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Pharmacist
Source of report MAH
Report outcome Unknown
Serious report? No

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectUnknown15 Milligram1 every 1 Day(s) Attention deficit/hyperactivity disorder

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Drug ineffective
Product complaint
Date modified: